Prostate Cancer Management Decisions from Germline and Somatic Testing
Leonard G. Gomella, MD, FACS, explores the role of germline and somatic testing in guiding prostate cancer management decisions.
Read MoreLeonard G. Gomella, MD, FACS | Aug 2025
Leonard G. Gomella, MD, FACS, explores the role of germline and somatic testing in guiding prostate cancer management decisions.
Read MoreE. David Crawford, MD | Aug 2025
E. David Crawford, MD, and the panel discuss a case of a 66-year-old with elevated PSA, MRI PIRADS 5 lesion, and PSA density of 0.11.
Read MoreJulia Maki, PhD | Aug 2025
Julia Maki, PhD, discusses the dissemination strategy for research summaries developed by the PLUS Consortium.
Read MoreMargit Fisch, MD, FEAPU, FEBU | Aug 2025
Margit Fisch, MD, FEAPU, FEBU, explores informing patients before urethroplasty, various surgical techniques, and possible complications.
Read MoreDavid M. Albala, MD | Aug 2025
David M. Albala, MD, explores telesurgery, highlighting its technological advancements, ethical considerations, and clinical potential.
Read More